Repligen Stock Current Ratio
| RGEN Stock | USD 167.05 0.74 0.44% |
Repligen fundamentals help investors to digest information that contributes to Repligen's financial success or failures. It also enables traders to predict the movement of Repligen Stock. The fundamental analysis module provides a way to measure Repligen's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Repligen stock.
| Last Reported | Projected for Next Year | ||
| Current Ratio | 7.02 | 9.00 |
Repligen | Current Ratio |
Repligen Company Current Ratio Analysis
Repligen's Current Ratio is calculated by dividing the Current Assets of a company by its Current Liabilities. It measures whether or not a company has enough cash or liquid assets to pay its current liability over the next fiscal year. The ratio is regarded as a test of liquidity for a company.
Current Repligen Current Ratio | 2.30 X |
Most of Repligen's fundamental indicators, such as Current Ratio, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Repligen is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Repligen Current Ratio Driver Correlations
Understanding the fundamental principles of building solid financial models for Repligen is extremely important. It helps to project a fair market value of Repligen Stock properly, considering its historical fundamentals such as Current Ratio. Since Repligen's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Repligen's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Repligen's interrelated accounts and indicators.
Click cells to compare fundamentals
Repligen Current Ratio Historical Pattern
Today, most investors in Repligen Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Repligen's growth ratios. Consistent increases or drops in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's current ratio growth rates may not be enough to decide which company is a better investment. That's why investors frequently use a static breakdown of Repligen current ratio as a starting point in their analysis.
Repligen Current Ratio |
| Timeline |
Typically, short-term creditors will prefer a high current ratio because it reduces their overall risk. However, investors may prefer a lower current ratio since they are more concerned about growing the business using assets of the company. Acceptable current ratios may vary from one sector to another, but the generally accepted benchmark is to have current assets at least as twice as current liabilities (i.e., Current Ration of 2 to 1).
| Competition |
Repligen Price To Sales Ratio
Price To Sales Ratio |
|
In accordance with the recently published financial statements, Repligen has a Current Ratio of 2.3 times. This is 20.96% lower than that of the Life Sciences Tools & Services sector and 34.29% lower than that of the Health Care industry. The current ratio for all United States stocks is 6.48% lower than that of the firm.
Repligen Current Ratio Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Repligen's direct or indirect competition against its Current Ratio to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Repligen could also be used in its relative valuation, which is a method of valuing Repligen by comparing valuation metrics of similar companies.Repligen is currently under evaluation in current ratio category among related companies.
Repligen Fundamentals
| Return On Equity | 0.0076 | ||||
| Return On Asset | 0.006 | ||||
| Profit Margin | 0.02 % | ||||
| Operating Margin | 0.01 % | ||||
| Current Valuation | 9.29 B | ||||
| Shares Outstanding | 55.88 M | ||||
| Shares Owned By Insiders | 6.58 % | ||||
| Shares Owned By Institutions | 93.42 % | ||||
| Number Of Shares Shorted | 4.59 M | ||||
| Price To Earning | 154.58 X | ||||
| Price To Book | 4.86 X | ||||
| Price To Sales | 14.99 X | ||||
| Revenue | 638.76 M | ||||
| Gross Profit | 455.71 M | ||||
| EBITDA | 131.39 M | ||||
| Net Income | 41.58 M | ||||
| Cash And Equivalents | 596.51 M | ||||
| Cash Per Share | 10.75 X | ||||
| Total Debt | 711.8 M | ||||
| Debt To Equity | 0.23 % | ||||
| Current Ratio | 2.30 X | ||||
| Book Value Per Share | 35.29 X | ||||
| Cash Flow From Operations | 113.92 M | ||||
| Short Ratio | 10.84 X | ||||
| Earnings Per Share | 0.27 X | ||||
| Price To Earnings To Growth | 2.59 X | ||||
| Target Price | 204.58 | ||||
| Number Of Employees | 1.78 K | ||||
| Beta | 1.01 | ||||
| Market Capitalization | 9.33 B | ||||
| Total Asset | 2.82 B | ||||
| Retained Earnings | 438.85 M | ||||
| Working Capital | 952.88 M | ||||
| Current Asset | 103.25 M | ||||
| Current Liabilities | 18.78 M | ||||
| Net Asset | 2.82 B |
About Repligen Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Repligen's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Repligen using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Repligen based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
When determining whether Repligen offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Repligen's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Repligen Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Repligen Stock:Check out Repligen Piotroski F Score and Repligen Altman Z Score analysis. To learn how to invest in Repligen Stock, please use our How to Invest in Repligen guide.Note that the Repligen information on this page should be used as a complementary analysis to other Repligen's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Stocks Directory module to find actively traded stocks across global markets.
Complementary Tools for Repligen Stock analysis
When running Repligen's price analysis, check to measure Repligen's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Repligen is operating at the current time. Most of Repligen's value examination focuses on studying past and present price action to predict the probability of Repligen's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Repligen's price. Additionally, you may evaluate how the addition of Repligen to your portfolios can decrease your overall portfolio volatility.
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Stocks Directory Find actively traded stocks across global markets |
Is Repligen's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Repligen. If investors know Repligen will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Repligen listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.93) | Earnings Share 0.27 | Revenue Per Share 10.892 | Quarterly Revenue Growth (0.17) | Return On Assets 0.006 |
The market value of Repligen is measured differently than its book value, which is the value of Repligen that is recorded on the company's balance sheet. Investors also form their own opinion of Repligen's value that differs from its market value or its book value, called intrinsic value, which is Repligen's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Repligen's market value can be influenced by many factors that don't directly affect Repligen's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Repligen's value and its price as these two are different measures arrived at by different means. Investors typically determine if Repligen is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Repligen's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.